BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11918517)

  • 1. Esomeprazole for acid peptic disorders.
    Kale-Pradhan PB; Landry HK; Sypula WT
    Ann Pharmacother; 2002 Apr; 36(4):655-63. PubMed ID: 11918517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esomeprazole magnesium (Nexium).
    Baker DE
    Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of esomeprazole in the treatment of acid disorders.
    Johnson DA
    Expert Opin Pharmacother; 2003 Feb; 4(2):253-64. PubMed ID: 12562316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole: a clinical review.
    Johnson TJ; Hedge DD
    Am J Health Syst Pharm; 2002 Jul; 59(14):1333-9. PubMed ID: 12132559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of esomeprazole in patients with acid-peptic disorders.
    Beck J
    Gastroenterol Nurs; 2004; 27(2):44-9. PubMed ID: 15082946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy.
    Thitiphuree S; Talley NJ
    Int J Clin Pract; 2000 Oct; 54(8):537-41. PubMed ID: 11198734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esomeprazole: a review of its use in the management of acid-related disorders.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of omeprazole use in the treatment of acid-related disorders in children.
    Zimmermann AE; Walters JK; Katona BG; Souney PE; Levine D
    Clin Ther; 2001 May; 23(5):660-79; discussion 645. PubMed ID: 11394727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators.
    Kahrilas PJ; Falk GW; Johnson DA; Schmitt C; Collins DW; Whipple J; D'Amico D; Hamelin B; Joelsson B
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1249-58. PubMed ID: 11012468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor.
    Tonini M; Vigneri S; Savarino V; Scarpignato C
    Dig Liver Dis; 2001 Oct; 33(7):600-6. PubMed ID: 11816552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esomeprazole: update and clinical review.
    Baker DE
    Rev Gastroenterol Disord; 2002; 2(4):189-99. PubMed ID: 12481170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
    J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.
    Lightdale CJ; Schmitt C; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):852-7. PubMed ID: 16773434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori.
    Wang X; Fang JY; Lu R; Sun DF
    Digestion; 2006; 73(2-3):178-86. PubMed ID: 16837803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and endoscopic evaluation of gastroesophageal reflux disease in patients successfully treated with esomeprazole.
    da Silva EP; Nader F; Quilici FA; Eisig JN; Zaterka S; Meneghelli U
    Arq Gastroenterol; 2003; 40(4):262-7. PubMed ID: 15264050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole.
    Spencer CM; Faulds D
    Drugs; 2000 Aug; 60(2):321-9; discussion 330-1. PubMed ID: 10983736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.
    Raghunath AS; Green JR; Edwards SJ
    Clin Ther; 2003 Jul; 25(7):2088-101. PubMed ID: 12946553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.